Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Metabolism ; 147: 155677, 2023 10.
Artigo em Inglês | MEDLINE | ID: mdl-37543245

RESUMO

Over the past few decades, there has been a global increase in childhood obesity. This rise in childhood obesity contributes to the susceptibility of impaired metabolism during both childhood and adulthood. The hypothalamus, specifically the arcuate nucleus (ARC), houses crucial neurons involved in regulating homeostatic feeding. These neurons include proopiomelanocortin (POMC) and agouti-related peptide (AGRP) secreting neurons. They play a vital role in sensing nutrients and metabolic hormones like insulin, leptin, and ghrelin. The neurogenesis of AGRP and POMC neurons completes at birth; however, axon development and synapse formation occur during the postnatal stages in rodents. Insulin, leptin, and ghrelin are the essential regulators of POMC and AGRP neurons. Maternal obesity and postnatal overfeeding or a high-fat diet (HFD) feeding cause metabolic inflammation, disrupted signaling of metabolic hormones, netrin-1, and neurogenic factors, neonatal obesity, and defective neuronal development in animal models; however, the mechanism is unclear. Within the hypothalamus and other brain areas, there exists a wide range of interconnected neuronal populations that regulate various aspects of feeding. However, this review aims to discuss how perinatal metabolic inflammation influences the development of POMC and AGRP neurons within the hypothalamus.


Assuntos
Leptina , Obesidade Infantil , Criança , Animais , Feminino , Humanos , Gravidez , Leptina/metabolismo , Grelina , Proteína Relacionada com Agouti , Obesidade Infantil/metabolismo , Pró-Opiomelanocortina/metabolismo , Hipotálamo/metabolismo , Núcleo Arqueado do Hipotálamo/metabolismo , Insulina/metabolismo
2.
Trends Cancer ; 7(6): 511-524, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-33358571

RESUMO

Despite the dramatic advances in cancer research over the decades, effective therapeutic strategies are still urgently needed. Increasing evidence indicates that connective tissue growth factor (CTGF), a multifunctional signaling modulator, promotes cancer initiation, progression, and metastasis by regulating cell proliferation, migration, invasion, drug resistance, and epithelial-mesenchymal transition (EMT). CTGF is also involved in the tumor microenvironment in most of the nodes, including angiogenesis, inflammation, and cancer-associated fibroblast (CAF) activation. In this review, we comprehensively discuss the expression of CTGF and its regulation, oncogenic role, clinical relevance, targeting strategies, and therapeutic agents. Herein, we propose that CTGF is a promising cancer therapeutic target that could potentially improve the clinical outcomes of cancer patients.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Fator de Crescimento do Tecido Conjuntivo/antagonistas & inibidores , Neoplasias/tratamento farmacológico , Proteínas Oncogênicas/antagonistas & inibidores , Animais , Anticorpos Monoclonais Humanizados/farmacologia , Anticorpos Monoclonais Humanizados/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Linhagem Celular Tumoral , Movimento Celular/efeitos dos fármacos , Movimento Celular/genética , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/genética , Ensaios Clínicos como Assunto , Fator de Crescimento do Tecido Conjuntivo/genética , Fator de Crescimento do Tecido Conjuntivo/metabolismo , Curcumina/farmacologia , Curcumina/uso terapêutico , Progressão da Doença , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Resistencia a Medicamentos Antineoplásicos/genética , Transição Epitelial-Mesenquimal/efeitos dos fármacos , Transição Epitelial-Mesenquimal/genética , Matriz Extracelular/metabolismo , Regulação Neoplásica da Expressão Gênica , Técnicas de Silenciamento de Genes , Humanos , Camundongos , Neoplasias/genética , Neoplasias/mortalidade , Neoplasias/patologia , Proteínas Oncogênicas/genética , Proteínas Oncogênicas/metabolismo , Prognóstico , Transdução de Sinais/efeitos dos fármacos , Taxa de Sobrevida , Microambiente Tumoral/efeitos dos fármacos , Microambiente Tumoral/genética , Ensaios Antitumorais Modelo de Xenoenxerto
3.
Adv Exp Med Biol ; 1090: 105-121, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30390287

RESUMO

The major function of brain glial cells is to maintain a homeostatic milieu for neurons to work properly in response to a variety of environmental alterations. Recent studies have shown that glial cells in the hypothalamus, a brain center controlling homeostatic physiological functions, are essential for regulating energy metabolism in both physiological and pathological conditions. Astrocytes, tanycytes, and NG2-glia shuttle and/or sense key metabolic factors presented to the hypothalamus either directly, by glial metabolic enzymes, receptors, and transporters, or indirectly, by modulating the sensing ability of other types of hypothalamic cells. Astrocytes, tanycytes, and microglia are critically important in the development and maintenance of hypothalamic circuits regulating energy balance. Hypothalamic inflammation commonly associated with diet-induced obesity is manifested via hypothalamic reactive gliosis involving microglia and astrocytes, contributing to the correlated abnormal energy metabolism. Although many glial functions in energy metabolism remain to be fully elucidated, we are at the dawn of targeting glia-neuron interactions in the hypothalamus for therapeutic applications in metabolic disorders.


Assuntos
Metabolismo Energético , Neuroglia/fisiologia , Astrócitos/fisiologia , Células Ependimogliais/fisiologia , Humanos , Hipotálamo/citologia , Microglia/fisiologia , Obesidade/patologia
4.
Cell Death Dis ; 9(2): 165, 2018 02 07.
Artigo em Inglês | MEDLINE | ID: mdl-29416003

RESUMO

Tanshinone IIA (Tan IIA), the primary bioactive compound derived from the traditional Chinese medicine (TCM) Salvia miltiorrhiza Bunge, has been reported to possess antitumor activity. However, its antitumor mechanisms are not fully understood. To resolve the potential antitumor mechanism(s) of Tan IIA, its gene expression profiles from our database was analyzed by connectivity map (CMAP) and the CMAP-based mechanistic predictions were confirmed/validated in further studies. Specifically, Tan IIA inhibited total protein kinase C (PKC) activity and selectively suppressed the expression of cytosolic and plasma membrane PKC isoforms ζ and ε. The Ras/MAPK pathway that is closely regulated by the PKC signaling is also inhibited by Tan IIA. While Tan IIA did not inhibit heat shock protein 90 (Hsp90), it synergistically enhanced the antitumor efficacy of the Hsp90 inhibitors 17-AAG and ganetespib in human breast cancer MCF-7 cells. In addition, Tan IIA significantly inhibited PI3K/Akt/mTOR signaling, and induced both cell cycle arrest and autophagy. Collectively, these studies provide new insights into the molecular mechanisms responsible for antitumor activity of Tan IIA.


Assuntos
Abietanos/farmacologia , Antineoplásicos Fitogênicos/farmacologia , Benzoquinonas/farmacologia , Produtos Biológicos/farmacologia , Lactamas Macrocíclicas/farmacologia , Proteína Quinase C/antagonistas & inibidores , Abietanos/química , Animais , Antineoplásicos Fitogênicos/química , Antineoplásicos Fitogênicos/uso terapêutico , Apoptose/efeitos dos fármacos , Autofagia/efeitos dos fármacos , Produtos Biológicos/química , Produtos Biológicos/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/genética , Neoplasias da Mama/patologia , Pontos de Checagem do Ciclo Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Sinergismo Farmacológico , Feminino , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Proteínas de Choque Térmico HSP90/metabolismo , Humanos , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Células MCF-7 , Camundongos Nus , Fosfatidilinositol 3-Quinases/metabolismo , Proteína Quinase C/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Serina-Treonina Quinases TOR/metabolismo , Triazóis/farmacologia , Ensaios Antitumorais Modelo de Xenoenxerto
5.
Neuropeptides ; 59: 9-20, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27255391

RESUMO

The physiology of reproduction is very complex and is regulated by multiple factors, including a number of hypothalamic neuropeptides. In last few decades, various neuropeptides have been discovered to be involved in stimulation or inhibition of reproduction. In 2000, Tsutsui and colleagues uncovered gonadotropin-inhibitory hormone (GnIH), a neuropeptide generating inhibitory drive to the reproductive axis, in the brain of Coturnix quail. Afterward, GnIH orthologs were discovered in other vertebrates from fish to mammals including human. In these vertebrates, all the discovered GnIH and its ortholgs have LPXRFamide (X=L or Q) sequence at C-terminus. GnIH orthologs of mammals and primates are also termed as RFamide-related peptide (RFRP)-1 and -3 that too have an LPXRFamide (X=L or Q) motif at their C-terminus. GnIH and its orthologs form a member of the RFamide peptide family. GnIH signals via its canonical G protein coupled receptor 147 (GPR147). Both GnIH and GPR147 are expressed in hypothalamus and other brain regions. Besides actions through the hypothalamic GnRH and kisspeptinergic neurons, GnIH-GPR147 signaling exerts inhibitory effect on the reproductive axis via pituitary gonadotropes and directly at gonadal level. Various factors including availability and quality of food, photoperiod, temperature, social interaction, various stresses and some diseases modulate GnIH-GPR147 signaling. In this review, we have discussed expression and actions of GnIH and its orthologs in vertebrates. Special emphasis is given on the role of GnIH-GPR147 signaling pathway in the regulation of reproduction. We have also reviewed and discussed currently available literature on the participation of GnIH-GPR147 signaling pathway in the stress modulation of reproduction.


Assuntos
Hormônios Hipotalâmicos/metabolismo , Hipotálamo/metabolismo , Neuropeptídeos/metabolismo , Reprodução/fisiologia , Animais , Coturnix , Feminino , Humanos , Neurônios/metabolismo , Hipófise/metabolismo , Transdução de Sinais/fisiologia
6.
J Nat Prod ; 77(1): 111-7, 2014 Jan 24.
Artigo em Inglês | MEDLINE | ID: mdl-24328138

RESUMO

Certain botanical dietary supplements have been associated with idiosyncratic organ-specific toxicity. Similar toxicological events, caused by drug-induced mitochondrial dysfunction, have forced the withdrawal or U.S. FDA "black box" warnings of major pharmaceuticals. To assess the potential mitochondrial liability of botanical dietary supplements, extracts from 352 authenticated plant samples used in traditional Chinese, Ayurvedic, and Western herbal medicine were evaluated for the ability to disrupt cellular respiration. Blue cohosh (Caulophyllum thalictroides) methanol extract exhibited mitochondriotoxic activity. Used by some U.S. midwives to help induce labor, blue cohosh has been associated with perinatal stroke, acute myocardial infarction, congestive heart failure, multiple organ injury, and neonatal shock. The potential link between mitochondrial disruption and idiosyncratic herbal intoxication prompted further examination. The C. thalictroides methanol extract and three saponins, cauloside A (1), saponin PE (2), and cauloside C (3), exhibited concentration- and time-dependent mitochondriotoxic activities. Upon treatment, cell respiration rate rapidly increased and then dramatically decreased within minutes. Mechanistic studies revealed that C. thalictroides constituents impair mitochondrial function by disrupting membrane integrity. These studies provide a potential etiological link between this mitochondria-sensitive form of cytotoxicity and idiosyncratic organ damage.


Assuntos
Caulophyllum/química , Respiração Celular/efeitos dos fármacos , Suplementos Nutricionais/toxicidade , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Ácido Oleanólico/análogos & derivados , Saponinas/toxicidade , Relação Dose-Resposta a Droga , Humanos , Estrutura Molecular , Ácido Oleanólico/química , Ácido Oleanólico/toxicidade , Fitoterapia , Saponinas/química , Estados Unidos
7.
J Nat Prod ; 76(4): 642-7, 2013 Apr 26.
Artigo em Inglês | MEDLINE | ID: mdl-23441686

RESUMO

Natural product drug discovery programs often rely on the use of silica (Si) gel, reversed-phase media, or size-exclusion resins (e.g., RP-C18, Sephadex LH-20) for compound purification. The synthetic polymer-based sorbent Diaion HP20SS (cross-linked polystyrene matrix) is used as an alternative to prepare purified natural product libraries. To evaluate the impact of chromatographic media on the isolation of biologically active, yet chromatographically unstable natural products, Diaion HP20SS was evaluated side-by-side with normal-phase sorbents for irreversible binding of extract constituents and their effects on bioactivity. An array of chemically diverse natural product-rich extracts was selected as a test panel, and a cell-based reporter assay for hypoxia-inducible factor-1 (HIF-1) was employed to monitor potential change(s) in bioactivity. Silica gel caused significant irreversible binding of three out of 10 extracts. Curcuma longa, Saururus cernuus, and Citrus reticulata extracts showed decreased HIF-1 inhibitory activity after elution through Si gel. An additional nonpolar column wash of HP20SS with EtOAc retained considerable bioactivities of active extracts. In general, Si gel produced the greatest loss of bioactivity. However, HP20SS elution reduced significantly HIF-1 inhibitory activity of certain extracts (e.g., Asimina triloba).


Assuntos
Fator 1 Induzível por Hipóxia/antagonistas & inibidores , Extratos Vegetais/química , Podophyllum/química , Asimina/química , Aspalathus/química , Produtos Biológicos , Cromatografia , Citrus/química , Curcuma/química , Cyclopia (Planta)/química , Dextranos , Feminino , Humanos , Lythraceae/química , Extratos Vegetais/análise , Saururaceae/química , Sílica Gel , Vaccinium macrocarpon/química
8.
Bioorg Med Chem ; 21(7): 1795-803, 2013 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-23434131

RESUMO

Bioassay-guided isolation and subsequent structure elucidation of a Bael tree Aegle marmelos lipid extract yielded two unstable acylated geranyloxycoumarin mixtures (1-2), six geranyloxycoumarins (3-8), (+)-9'-isovaleroxylariciresinol (9), and dehydromarmeline (10). In a T47D cell-based reporter assay, 1 and 2 potently inhibited hypoxia-induced HIF-1 activation (IC50 values 0.18 and 1.10 µgmL(-1), respectively). Insufficient material and chemical instability prevented full delineation of the fatty acyl side chain olefin substitution patterns in 1 and 2. Therefore, five fatty acyl geranyloxycoumarin ester derivatives (11-15) were prepared from marmin (3) and commercial fatty acyl chlorides by semisynthesis. The unsaturated C-6' linoleic acid ester derivative 14 that was structurally most similar to 1 and 2, inhibited HIF-1 activation with comparable potency (IC50 0.92 µM). The octanoyl (11) and undecanoyl (12) ester derivatives also suppressed HIF-1 activation (IC50 values 3.1 and 0.87 µM, respectively). Mechanistic studies revealed that these geranyloxycoumarin derivatives disrupt mitochondrial respiration, primarily at complex I. Thus, these compounds may inhibit HIF-1 activation by suppressing mitochondria-mediated hypoxic signaling. One surprising observation was that, while less potent, the purported cancer chemopreventive agent auraptene (8) was found to act as a mitochondrial poison that disrupts HIF-1 signaling in tumors.


Assuntos
Aegle/química , Cumarínicos/química , Cumarínicos/toxicidade , Fator 1 Induzível por Hipóxia/antagonistas & inibidores , Mitocôndrias/efeitos dos fármacos , Extratos Vegetais/química , Extratos Vegetais/toxicidade , Antineoplásicos Fitogênicos/química , Antineoplásicos Fitogênicos/isolamento & purificação , Antineoplásicos Fitogênicos/farmacologia , Antineoplásicos Fitogênicos/toxicidade , Mama/efeitos dos fármacos , Mama/patologia , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/patologia , Linhagem Celular , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Respiração Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Cumarínicos/isolamento & purificação , Cumarínicos/farmacologia , Suplementos Nutricionais/efeitos adversos , Suplementos Nutricionais/análise , Feminino , Humanos , Fator 1 Induzível por Hipóxia/metabolismo , Mitocôndrias/metabolismo , Mitocôndrias/patologia , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia
9.
Science ; 334(6059): 1133-7, 2011 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-22116886

RESUMO

Evolutionarily old and conserved homeostatic systems in the brain, including the hypothalamus, are organized into nuclear structures of heterogeneous and diverse neuron populations. To investigate whether such circuits can be functionally reconstituted by synaptic integration of similarly diverse populations of neurons, we generated physically chimeric hypothalami by microtransplanting small numbers of embryonic enhanced green fluorescent protein-expressing, leptin-responsive hypothalamic cells into hypothalami of postnatal leptin receptor-deficient (db/db) mice that develop morbid obesity. Donor neurons differentiated and integrated as four distinct hypothalamic neuron subtypes, formed functional excitatory and inhibitory synapses, partially restored leptin responsiveness, and ameliorated hyperglycemia and obesity in db/db mice. These experiments serve as a proof of concept that transplanted neurons can functionally reconstitute complex neuronal circuitry in the mammalian brain.


Assuntos
Hipotálamo Médio/citologia , Hipotálamo Médio/fisiopatologia , Hipotálamo/citologia , Leptina/metabolismo , Neurônios/fisiologia , Neurônios/transplante , Obesidade/fisiopatologia , Obesidade/terapia , Receptores para Leptina/metabolismo , Animais , Glicemia/análise , Peso Corporal , Forma Celular , Fenômenos Eletrofisiológicos , Potenciais Pós-Sinápticos Excitadores , Glucose/administração & dosagem , Hipotálamo/metabolismo , Hipotálamo Médio/metabolismo , Potenciais Pós-Sinápticos Inibidores , Insulina/administração & dosagem , Insulina/sangue , Leptina/administração & dosagem , Potenciais da Membrana , Camundongos , Camundongos Obesos , Neurogênese , Neurônios/citologia , Obesidade/metabolismo , Transdução de Sinais , Transmissão Sináptica
10.
J Nat Prod ; 73(5): 956-61, 2010 May 28.
Artigo em Inglês | MEDLINE | ID: mdl-20423107

RESUMO

Products that contain twig extracts of pawpaw (Asimina triloba) are widely consumed anticancer alternative medicines. Pawpaw crude extract (CE) and purified acetogenins inhibited hypoxia-inducible factor-1 (HIF-1)-mediated hypoxic signaling pathways in tumor cells. In T47D cells, pawpaw CE and the acetogenins 10-hydroxyglaucanetin (1), annonacin (2), and annonacin A (3) inhibited hypoxia-induced HIF-1 activation with IC(50) values of 0.02 microg/mL, 12 nM, 13 nM, and 31 nM, respectively. This inhibition correlates with the suppression of the hypoxic induction of HIF-1 target genes VEGF and GLUT-1. The induction of secreted VEGF protein represents a key event in hypoxia-induced tumor angiogenesis. Both the extract and the purified acetogenins blocked the angiogenesis-stimulating activity of hypoxic T47D cells in vitro. Pawpaw extract and acetogenins inhibited HIF-1 activation by blocking the hypoxic induction of nuclear HIF-1alpha protein. The inhibition of HIF-1 activation was associated with the suppression of mitochondrial respiration at complex I. Thus, the inhibition of HIF-1 activation and hypoxic tumor angiogenesis constitutes a novel mechanism of action for these anticancer alternative medicines.


Assuntos
Acetogeninas/isolamento & purificação , Acetogeninas/farmacologia , Antineoplásicos Fitogênicos/isolamento & purificação , Antineoplásicos Fitogênicos/farmacologia , Asimina/química , Transportador de Glucose Tipo 1/efeitos dos fármacos , Fator 1 Induzível por Hipóxia/efeitos dos fármacos , Neovascularização Fisiológica/efeitos dos fármacos , Plantas Medicinais/química , Fatores de Crescimento do Endotélio Vascular/efeitos dos fármacos , Acetogeninas/química , Antineoplásicos Fitogênicos/química , Terapias Complementares , Ensaios de Seleção de Medicamentos Antitumorais , Transportador de Glucose Tipo 1/análise , Transportador de Glucose Tipo 1/genética , Humanos , Concentração Inibidora 50 , Estrutura Molecular , Fatores de Crescimento do Endotélio Vascular/análise , Fatores de Crescimento do Endotélio Vascular/genética
11.
Phytochemistry ; 67(17): 1849-55, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16876833

RESUMO

The compound (-)-epigallocatechin-3-gallate (EGCG) is the major catechin found in green tea [Camellia sinensis L. Ktze. (Theaceae)]. This polyphenolic compound and several related catechins are believed to be responsible for the health benefits associated with the consumption of green tea. The potential health benefits ascribed to green tea and EGCG include antioxidant effects, cancer chemoprevention, improving cardiovascular health, enhancing weight loss, protecting the skin from the damage caused by ionizing radiation, and others. The compound EGCG has been shown to regulate dozens of disease-specific molecular targets. Many of these molecular targets are only affected by concentrations of EGCG that are far above the levels achieved by either drinking green tea or consuming moderate doses of green tea extract-based dietary supplements. In spite of this, well-designed double-blinded controlled clinical studies have recently demonstrated the efficacy of green tea extracts and purified EGCG products in patients. Therefore, this review highlights results from what the authors believe to be some of the most clinically significant recent studies and describes current developments in the stereoselective total synthesis of EGCG.


Assuntos
Anticarcinógenos/uso terapêutico , Antioxidantes/uso terapêutico , Catequina/análogos & derivados , Animais , Anticarcinógenos/farmacologia , Antioxidantes/farmacologia , Catequina/farmacologia , Catequina/uso terapêutico , Humanos , Estrutura Molecular , Neoplasias/prevenção & controle , Pele/efeitos dos fármacos , Chá/química
12.
J Nat Prod ; 67(12): 2063-9, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15620252

RESUMO

Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that induces oxygen-regulated genes in response to reduced oxygen conditions (hypoxia). Expression of the oxygen-regulated HIF-1alpha subunit correlates positively with advanced disease stages and poor prognosis in cancer patients. Green tea catechins are believed to be responsible for the cancer chemopreventive activities of green tea. We found that (-)-epicatechin-3-gallate (ECG, 1), one of the major green tea catechins, strongly activates HIF-1 in T47D human breast carcinoma cells. Among the green tea catechins tested, 1 demonstrated the strongest HIF-1-inducing activity, while (-)-epigallocatechin-3-gallate (EGCG, 2) was significantly less active. However, 2 is relatively unstable in the in vitro system studied. Compound 1 also increases the expression of HIF-1 target genes including GLUT-1, VEGF, and CDKN1A. In T47D cells, 1 induces nuclear HIF-1alpha protein without affecting HIF-1alpha mRNA. Both the induction of HIF-1alpha protein and activation of HIF-1 by 1 can be blocked by iron and ascorbate, indicating that 1 may activate HIF-1 through the chelation of iron. These results suggest that intended cancer chemoprevention with high-dose green tea extracts may be compromised, by the ability of tea catechins to promote tumor cell survival pathways associated with HIF-1 activation.


Assuntos
Catequina/análogos & derivados , Catequina/farmacologia , Proteínas de Ligação a DNA , Proteínas Nucleares , Chá , Fatores de Transcrição , Hipóxia Celular/efeitos dos fármacos , Hipóxia Celular/genética , Proteínas de Ligação a DNA/efeitos dos fármacos , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/fisiologia , Humanos , Fator 1 Induzível por Hipóxia , Subunidade alfa do Fator 1 Induzível por Hipóxia , Estrutura Molecular , Proteínas Nucleares/efeitos dos fármacos , Proteínas Nucleares/genética , Proteínas Nucleares/fisiologia , Estereoisomerismo , Relação Estrutura-Atividade , Fatores de Transcrição/efeitos dos fármacos , Fatores de Transcrição/genética , Fatores de Transcrição/fisiologia , Fator A de Crescimento do Endotélio Vascular/efeitos dos fármacos
13.
J Nat Prod ; 67(5): 767-71, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15165135

RESUMO

The transcription factor hypoxia-inducible factor-1 (HIF-1) is a key regulator of tumor cell adaptation and survival under hypoxic conditions. Selective HIF-1 inhibitors represent an important new class of potential molecular-targeted antitumor therapeutic agents. Extracts of plants and marine organisms were evaluated using a T47D human breast tumor cell-based reporter assay for HIF-1 inhibitors. Bioassay-guided fractionation of the lipid extract of Saururus cernuus resulted in the isolation of manassantin B (1) and a new compound, 4-O-demethylmanassantin B (2). The structure of 2 was determined spectroscopically. The absolute configurations of manassantin-type dineolignans have not been previously reported. Therefore, the absolute configurations of the chiral centers in each side chain were deduced from spectroscopic analysis of the Mosher MTPA ester derivatives of 1. Both 1 and 2 are among the most potent small molecule HIF-1 inhibitors discovered, to date, with IC(50) values of 3 and 30 nM, respectively. Compounds 1 and 2 selectively inhibited hypoxia-activated HIF-1 in contrast to iron chelator-activated HIF-1. Compounds 1 and 2 also inhibited hypoxic induction of the angiogenic factor VEGF. Further study revealed that 1 selectively blocked the induction of HIF-1alpha protein, the oxygen regulated HIF-1 subunit that determines HIF-1 activity.


Assuntos
Antineoplásicos Fitogênicos/isolamento & purificação , Antineoplásicos Fitogênicos/farmacologia , Proteínas de Ligação a DNA/antagonistas & inibidores , Furanos/isolamento & purificação , Furanos/farmacologia , Hipóxia , Lignanas/isolamento & purificação , Lignanas/farmacologia , Proteínas Nucleares/antagonistas & inibidores , Plantas Medicinais/química , Saururaceae/química , Antineoplásicos Fitogênicos/química , Relação Dose-Resposta a Droga , Ensaio de Imunoadsorção Enzimática , Furanos/química , Fator 1 Induzível por Hipóxia , Concentração Inibidora 50 , Lignanas/química , Estereoisomerismo , Relação Estrutura-Atividade , Fatores de Transcrição/antagonistas & inibidores , Fator A de Crescimento do Endotélio Vascular/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA